| Bioactivity | Sultosilic acid piperazine salt (Piperazine sultosylate; A-585) is a lipid-lowering agent. Sultosilic acid piperazine salt modifies the blood lipids levels, reduces platelet adhesiveness without promoting peroxisomal activity of hepatocytes or producing other adverse side-effects[1]. |
| CAS | 57775-27-6 |
| Formula | C17H22N2O7S2 |
| Molar Mass | 430.50 |
| Appearance | 固体 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
| Reference | [1]. Vinazzer H, et al., Double-blind cross-over study of the effect of sultosilic acid piperazine salt (A-585) and bezafibrate in primary hyperlipoproteinemia. Atherosclerosis. 1983 Nov;49(2):109-18. |
Sultosilic acid piperazine salt
CAS: 57775-27-6 F: C17H22N2O7S2 W: 430.50
Sultosilic acid piperazine salt (Piperazine sultosylate; A-585) is a lipid-lowering agent. Sultosilic acid piperazine sa
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.